Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avalo Therapeutics (AVTX)
NASDAQ:AVTX
Avalo Therapeutics (AVTX) Stock Price & Analysis
865 Followers
AVTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.95 - $71.42
Previous Close$12.78
Volume5.69K
Average Volume (3M)31.53K
Market Cap
$13.21M
Enterprise Value-$96.96M
Total Cash (Recent Filing)$110.18M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Aug 01, 2024EPS Estimate
-$6.7Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-318.89
Shares Outstanding1,034,130
10 Day Avg. Volume20,931
30 Day Avg. Volume31,534
Standard Deviation0.59
R-Squared0.01
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)-4.22
Price to Sales (P/S)7.01
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-110.31
Enterprise Value/Gross Profit-151.50
Enterprise Value/Ebitda3.85
Forecast
1Y Price Target
$35.00Price Target Upside178.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Avalo Therapeutics News
PremiumCompany Announcements
Avalo Therapeutics Welcomes New CMO with Competitive Package
PremiumCompany Announcements
Avalo Therapeutics Welcomes New Chief Legal Officer Paul Varki
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AVTX FAQ
What was Avalo Therapeutics’s price range in the past 12 months?
Avalo Therapeutics lowest stock price was $3.95 and its highest was $71.42 in the past 12 months.
What is Avalo Therapeutics’s market cap?
Currently, no data Available
When is Avalo Therapeutics’s upcoming earnings report date?
Avalo Therapeutics’s upcoming earnings report date is Aug 01, 2024 which is in 9 days.
How were Avalo Therapeutics’s earnings last quarter?
Avalo Therapeutics released its earnings results on May 13, 2024. The company reported -$141 earnings per share for the quarter, missing the consensus estimate of -$1.18 by -$139.82.
Is Avalo Therapeutics overvalued?
According to Wall Street analysts Avalo Therapeutics’s price is currently Undervalued.
Does Avalo Therapeutics pay dividends?
Avalo Therapeutics does not currently pay dividends.
What is Avalo Therapeutics’s EPS estimate?
Avalo Therapeutics’s EPS estimate is -$6.7.
How many shares outstanding does Avalo Therapeutics have?
Avalo Therapeutics has 1,034,130 shares outstanding.
What happened to Avalo Therapeutics’s price movement after its last earnings report?
Avalo Therapeutics reported an EPS of -$141 in its last earnings report, missing expectations of -$1.18. Following the earnings report the stock price went down -0.276%.
Which hedge fund is a major shareholder of Avalo Therapeutics?
Currently, no hedge funds are holding shares in AVTX
---
Avalo Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$35.00 (178.22% Upside)
$35.00 (178.22% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 7.6%
Last 30 Days ▼ 7.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-82.82%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
241.46%
Trailing 12-Months
Company Description
Avalo Therapeutics
Cerecor, Inc. is a clinical stage biopharmaceutical company focuses in medical development. It involves in the discovery, manufacture and commercialization of prescription for neurological and psychiatric disorders. It products include CERC-301, CERC-501, CERC-611, and CERC-406. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher and Solomon H. Snyder on January 31, 2011 and is headquartered in Baltimore, MD.
---
AVTX Stock 12 Month Forecast
Average Price Target
$35.00
▲(178.22% Upside)
Technical Analysis
Best Analysts Covering AVTX
1 Year
1 Year Success Rate
4/15 ratings generated profit
1 Year Average Return
-38.84%
reiterated a buy rating 11 days ago
Copying Leland Gershell's trades and holding each position for 1 Year would result in 26.67% of your transactions generating a profit, with an average return of -38.84% per trade.
---